¿¬¼ö°­ÁÂ
´ëÇѽÉÀåÇÐȸ 2023³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Ãá°è¿¬¼ö°­Á : 2023-04-29

´ëÇѽÉÀåÇÐȸ 2023³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Ãá°è¿¬¼ö°­Á : 2023-04-29
±³À°ÀÏÀÚ : 2023-04-29
±³À°Àå¼Ò : º¤½ºÄÚ Á¦2Àü½ÃÀå 1Ãþ 121È£

±³À°ÁÖÁ¦ : 2023³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Ãá°è¿¬¼ö°­ÁÂ

ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ¿ï°æÁöȸ

´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 051-000-0000

À̸ÞÀÏ : sericonf@gmail.com

±³À°Á¾·ù : ³»°ú, ÀÇ»çÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇ·áÁ¤Ã¥, ±âŸ

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 7 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 09:00~09:15 Optimal antiplatelet strategy in patients both at high ischemic and bleeding risks ¾È¼­Èñ(¿ï»ê´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 09:15~09:30 Optimal revascularization strategy for ICMP ±è¼öÈ«(ºÎ»ê º¸Èƺ´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 09:30~09:45 Early versus delayed intervention for NSTEMI patients ±èÇÑ°á(°æ»ó±¹¸³´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 09:45~10:00 Physiology guided vs imaging guided PCI ¿ÀÁØÇõ(ºÎ»ê´ëº´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 10:00~10:20 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 10:20~10:30 Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 10:30~10:45 Practical tips for diagnosing HFpEF, featuring concept of congestion ÀåÁ¤À±(â¿ø°æ»ó´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 10:45~11:00 How to implement 4 pillar therapy in HFrEF À̼ö¿ë(¾ç»êºÎ»ê´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 11:00~11:15 How to detect & treat ATTR amyloidosis in daily practice ¼­Á¤¼÷(ºÎ»ê¹éº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 11:15~11:30 Approach to asymptomatic coronary artery calcium in chest CT ±èºÀÁØ(°í½Å´ëº¹À½º´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 11:30~11:50 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 11:50~12:00 Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 12:00~12:30 Earlier & Lower is Better! - Clinical Benefits of Evolocumab in ACS Á¶¿ë¶ô(µ¿¾Æ´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 12:30~13:00 Familial Hypercholesterolemia: It¡¯s Possible! How to Screen and Treat? ¹Ú°æ¹Î(¿ï»ê´ëº´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 13:00~13:15 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 13:15~13:30 Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 13:30~13:45 SGLT2 inhibitor and AF Ȳ±â¿ø(¾ç»êºÎ»ê´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 13:45~14:00 The use of non‐vitamin K oral anticoagulants in patients with AF and dialysis °ûÇýºó(â¿ø»ï¼ºº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 14:00~14:15 Left Bundle Branch Pacing Versus Biventricular Pacing In heart failure ¹Ú¿µ¾Æ(ºÎ»ê¹éº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 14:15~14:30 New Technology in AF Ablation: Pulsed Field Ablation ÀÓ¼ºÀÏ(°í½Å´ëº¹À½º´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 14:30~14:50 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 14:50~15:00 Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 15:00~15:45 Patient indication & assessment of TEER during procedure ¹Ú¼ºÁö(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 15:45~16:30 A to Z of TEER procedures ÇÑÁÖ¿ë(»ï¼º¼­¿ïº´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 16:30~16:50 Discussion ( )

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­Á : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ¿Â¶óÀÎ »ýÁß°è ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ ´ã´çÀÚ : °û¼ÖÀÌ ¿¬¶ôó : 02-71

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,334 , ´ñ±Û¼ö : 0

[ºÎ»ê] 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-04-17

±³À°ÀÏÀÚ : 2024-04-17 ±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ ºÎ»ê ±³À°ÁÖÁ¦ : 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ ´ã´çÀÚ : °­ÈÆ ¿¬¶ôó

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,177 , ´ñ±Û¼ö : 0

[¼­¿ï] Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialysis Vascular Access) : 2024-03-31

±³À°ÀÏÀÚ : 2024-03-31 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ ±³À°ÁÖÁ¦ : Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialy

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,281 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ) Á¦9ȸ ºñ¸¸Àü¹®°¡ ±âÃÊ°úÁ¤ : 2024-04-28

±³À°ÀÏÀÚ : 2024-04-28 ±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦9ȸ ºñ¸¸Àü¹®°¡ ±âÃÊ°úÁ¤ ÁÖÃÖ±â°ü : ´ëÇѺñ¸¸ÇÐȸ ´ã´çÀÚ : ÃÖÀ±Áö ¿¬¶ôó : 02-6941-087

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,146 , ´ñ±Û¼ö : 0

[¼­¿ï] ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú ¿¬¼ö°­Á (ÀüÁ¾°ü ±³¼ö´Ô ¸í¿¹ÅðÀÓ ±â³ä) : 2024-02-25

±³À°ÀÏÀÚ : 2024-02-25 ±³À°Àå¼Ò : ¼­¿ï´ëÇб³º´¿ø º»°ü ÁöÇÏ 1Ãþ ±èÁ¾±â Ȧ ±³À°ÁÖÁ¦ : ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú ¿¬¼ö°­Á (ÀüÁ¾°ü ±³¼ö´Ô ¸í¿¹ÅðÀÓ ±â³ä)ÁÖÃÖ±â°ü : ¼­

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,419 , ´ñ±Û¼ö : 0